Effects of μ-, δ- and κ-opioid antagonists in atrial preparations from nonfailing and failing human hearts

General Pharmacology

Volumn 28, Issue 3, 1997, Pages 371-374

  Llobel, F ^a   Laorden, M L ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

heart failure; human; opioid antagonists

Indexed keywords

CALCIUM ANTAGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; NITRATE; NORBINALTORPHIMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; FEMALE; HEART ATRIUM CONTRACTILITY; HEART FAILURE; HEART SURGERY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADULT; AGED; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART; HEART ATRIA; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MYOCARDIAL CONTRACTION; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0031044265     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00221-2     Document Type: Article

References (25)

1. Daly P. A. and Sole M. J. (1990) Myocardial catecholamines and the pathophysiology of heart failure. Circulation 82, I-35-I-43.
2. Feldman M. A. (1993) Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation 8, IV-27-IV-34.
3. Fontana F., Bernardi P., Pich E. M., Capelli M., Bortoluzzi L., Spampinato S. and Canossa M. (1993) Relationship between plasma atrial natriuretic factor and opioid peptide. Eur. Heart J. 14, 219-225.
4. Gautret B. H. and Schmitt H. (1984). Cardiac slowing induced by peripheral κ-opioid receptors in rats. Eur. J. Pharmacol. 102, 159-161.
5. Goldstein A. and Naidu A. (1989) Multiple opioid receptors: ligand selectivity profiles and binding signatures. Mol. Pharmacol. 36, 265-272.
6. Himura Y., Liang C. S., Imai N., Delehanty J. M., Woolf P. D. and Hood W. B. (1994) Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure. J. Am. Coll. Cardiol. 23, 194-200.
7. Holaday J. W. (1983) Cardiovascular consequences of endogenous opiate antagonists. Biochem. Pharmacol. 32, 573-583.
8. Hughes H., Kosterliz H. W. and Smith T. W. (1977) The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br. J. Pharmacol. 61, 14-23.
9. Kindman L. A., Kates R. E. and Ginsburg R. (1991) Opioids potentiate contractile response of rabbit myocardium to the beta agonist isoproterenol. J. Cardiovasc. Pharmacol. 17, 61-67.
10. Krumins S. A., Faden A. L. and Feuerstein G. (1985) Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biophys. Res. Comm. 127, 120-128.
11. Kumakara K., Karoum F., Guidotti A. and Costa E. (1980) Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells. Nature 283, 489-492.
12. Laorden M. L., Hernández J., Carceles M. D., Miralles F. S. and Puig M. M. (1990) Interaction between halothane and morphine on isolated heart muscle. Eur. J. Pharmacol. 175, 285-290.
13. Ledda F., Corti B. and Mantelli L. (1989) Indirect evidence for a role of prostaglandins as second messengers of the prejunctional effects of opioids in guinea-pig ventricular preparations. Eur. J. Pharmacol. 162, 323-327.
14. Liang C. S., Imai N., Stone C. K., Woolf P. D., Kawashima S. and Tuttle R. R. (1987) The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs. Circulation 75, 443-451.
15. Lowe H. (1991) Role of endogenous opioids in heart failure. Z. Kardiologie 8, 45-71.
16. Llobel F. and Laorden M. L. (1996) Effects of morphine on atrial preparations obtained from nonfailing and failing human hearts. Br, J. Anaesthesiol. 76, 106-110.
17. Llobel F. and Laorden M. L. (1996) Effects of μ-, δ- and κ-opioid agonists in the failing human myocardium. Neuropeptides 29, 115-119.
18. Mantelli K., Corti V. and Ledda F. (1987) On the presence of opioid receptors in the guinea-pig ventricular tissue. Gen. Pharmacol. 18, 309-311.
19. Micol J. A. and Laorden M. L. (1993) Effects of U-50,488H on isolated left atria of the rat. Pharmocol. Comm. 3, 63-71.
20. Micol J. A. and Laorden M. L. (1994) Effects of μ-, δ-, and κ-opioid agonists on isolated right atria of the rat. Neuropeptides 26, 365-370.
21. Portoghese P. S., Sultana M. and Takemori A. E. (1990) Design of peptidomimetics δ-opioid receptor antagonism using the message-address concept. J. Med. Chem. 33, 1714-1720.
22. Pugsley M. K., Pennz W. P., Walker M. J. K. and Woong T. M. (1992) Cardiovascular action of the κ-agonist, U-50,488H, in the absence and presence of opioid receptor blocked. Br. J. Pharmacol. 105, 521-526.
23. Takemori A. E., Ho B. Y., Naeseth J. S. and Portoghese P. S. (1989) Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246, 255-258.
24. Tallarida R. J. and Murray R. B. (1987) Manual of Pharmacologic Calculations with Computer Programs. Springer Verlag, New York.
25. Van Vliet B. J., Ruuls S. R., Drukarch B., Mulder A. H. and Schoffelmeer A. N. M. (1991) β-Adrenoceptor-sensitive adenylate cyclase is inhibited by activation of μ-opioid receptors in rat striatal neurons. Eur. J. Pharmacol. 195, 295-297.